(Reuters) -Digital health startup Hinge Health said on Wednesday it had raised $437.3 million in its U.S. initial public offering, after pricing shares at the higher end of its marketed range.
The company sold about 13.7 million shares at $32 per share, compared with its marketed range of $28 to $32 apiece.
Even at the top of its proposed range, Hinge Health’s target is nearly 52% lower than its $6.2 billion valuation from the 2021 Series E round, led by Coatue Management and Tiger Global.
The company will list on the New York Stock Exchange on Thursday, under the symbol “HNGE”.
Morgan Stanley, Barclays Capital and BofA Securities are the lead underwriters for the offering.
Founded in 2014 by Daniel Perez and Gabriel Mecklenburg, Hinge Health’s platform leverages artificial intelligence to provide at-home musculoskeletal care, chronic pain management, and post-surgical rehabilitation.
De-escalation in U.S.-China trade tensions has helped in the revival of the IPO market, which saw a period of subdued activity in early 2025.
(Reporting by Jaiveer Singh Shekhawat, Pritam Biswas and Devika Nair in Bengaluru; Editing by Vijay Kishore)
Comments